Cabot Corporation $CBT Shares Sold by Fox Run Management L.L.C.

Key Points

• Fox Run Management L.L.C. has reduced its stake in Cabot Corporation by 56.7% in the first quarter, now owning 2,558 shares valued at $213,000.
• Several institutional investors, including Copeland Capital Management and LSV Asset Management, have increased their positions in Cabot, indicating a strong institutional interest in the company.
• Cabot Corporation recently declared a quarterly dividend of $0.45 per share, with a dividend yield of 2.3%, demonstrating its commitment to returning value to shareholders.

Fox Run Management L.L.C. lowered its stake in shares of Cabot Corporation (NYSE:CBT - Free Report) by 56.7% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,558 shares of the specialty chemicals company's stock after selling 3,346 shares during the quarter. Fox Run Management L.L.C.'s holdings in Cabot were worth $213,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Banque Cantonale Vaudoise acquired a new position in shares of Cabot during the 1st quarter valued at about $43,000. CWM LLC increased its stake in shares of Cabot by 55.0% during the 1st quarter. CWM LLC now owns 600 shares of the specialty chemicals company's stock valued at $50,000 after acquiring an additional 213 shares during the last quarter. Curat Global LLC acquired a new position in shares of Cabot during the 1st quarter valued at about $83,000. Farther Finance Advisors LLC increased its stake in shares of Cabot by 1,346.4% during the 1st quarter. Farther Finance Advisors LLC now owns 1,620 shares of the specialty chemicals company's stock valued at $136,000 after acquiring an additional 1,508 shares during the last quarter. Finally, GAMMA Investing LLC increased its stake in shares of Cabot by 26.1% during the 1st quarter. GAMMA Investing LLC now owns 1,700 shares of the specialty chemicals company's stock valued at $141,000 after acquiring an additional 352 shares during the last quarter. Institutional investors and hedge funds own 93.18% of the company's stock.

Insider Activity

In other Cabot news, CEO Sean D. Keohane sold 114,436 shares of the company's stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $79.28, for a total value of $9,072,486.08. Following the transaction, the chief executive officer directly owned 361,518 shares of the company's stock, valued at $28,661,147.04. This represents a 24.04% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 3.03% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of research firms have recently commented on CBT. Wall Street Zen downgraded shares of Cabot from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th. UBS Group set a $82.00 target price on Cabot and gave the stock a "neutral" rating in a report on Tuesday, August 5th. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $92.33.

Cabot Stock Up 0.2%

NYSE CBT traded up $0.19 on Tuesday, reaching $81.75. The company had a trading volume of 210,966 shares, compared to its average volume of 432,504. The firm has a market capitalization of $4.35 billion, a PE ratio of 10.69 and a beta of 0.87. Cabot Corporation has a 1 year low of $70.40 and a 1 year high of $117.46. The firm has a 50-day moving average of $77.01 and a 200-day moving average of $78.80. The company has a debt-to-equity ratio of 0.66, a current ratio of 2.13 and a quick ratio of 1.41.

Cabot (NYSE:CBT - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The specialty chemicals company reported $1.90 earnings per share for the quarter, topping analysts' consensus estimates of $1.80 by $0.10. The firm had revenue of $923.00 million during the quarter, compared to analysts' expectations of $957.29 million. Cabot had a return on equity of 25.68% and a net margin of 11.14%. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS. On average, equities research analysts anticipate that Cabot Corporation will post 7.57 EPS for the current fiscal year.

Cabot Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 11th. Shareholders of record on Friday, August 29th will be given a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.2%. Cabot's payout ratio is 23.53%.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.